Publications by authors named "Isabelle Chabot"

Claim this Profile
D
Disease landscape of advanced HER2-breast cancer patients by treatment line in three EU countries and USA.
Kerigo Ndirangu, Isabelle Chabot, Katie Lewis, Annabel Lambert, Qi Zhao

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-examining the factor structure of the Insomnia Severity Index (ISI) and defining the meaningful within-individual change (MWIC) for subjects with insomnia disorder in two phase III clinical trials of the efficacy of lemborexant.
William R Lenderking, Yulia Savva, Mark J Atkinson, Renee Campbell, Isabelle Chabot

J Patient Rep Outcomes· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the unmet needs in insomnia treatment: a systematic literature review of real-world evidence.
Renee Campbell, Isabelle Chabot, Ben Rousseau, Daisy Bridge, Gillian Nicol

Int J Neurosci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy.
Alexandre Marineau, Catherine St-Pierre, Roxanne Lessard-Hurtubise, Marie-Ève David, Jean-Philippe Adam, Isabelle Chabot

J Oncol Pharm Pract· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a community pharmacy-based intervention for patients with uncontrolled asthma.
Claudie Turcotte, Rébecca Fénélon-Dimanche, Catherine Lemière, Marie-France Beauchesne, Bachir Abou-Atmé, Isabelle Chabot

Explor Res Clin Soc Pharm· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pre-Phase III Efficacy Trial of the Spermicide/Contraceptive Effect of the Invisible Condom, a Non-Hormonal Vaginal Gel, in Women from Canada.
Rabeea F Omar, Mathieu Leboeuf, Madeleine Lemyre, Isabelle Chabot, Sylvie Trottier

J Obstet Gynaecol Can· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer.
Qi Zhao, Rachel Hughes, Binod Neupane, Kristin Mickle, Yun Su, Isabelle Chabot

BMC Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in pediatric patients with partial onset seizures or primary generalized tonic-clonic seizures receiving adjunctive perampanel.
Andrew Trigg, Elaine Brohan, Kim Cocks, Amy Jones, Amir A Tahami Monfared, Isabelle Chabot

Epilepsy Behav· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer.
Isabelle Chabot, Qi Zhao, Yun Su

Curr Med Res Opin· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The initial state of the human gut microbiome determines its reshaping by antibiotics.
Frédéric Raymond, Amin A Ouameur, Maxime Déraspe, Naeem Iqbal, Hélène Gingras, Isabelle Chabot

ISME J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review.
Angela Rocchi, Isabelle Chabot, Judith Glennie

Clinicoecon Outcomes Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncology drug health technology assessment recommendations: Canadian versus UK experiences.
Isabelle Chabot, Angela Rocchi

Clinicoecon Outcomes Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How do cost-effectiveness analyses inform reimbursement decisions for oncology medicines in Canada? The example of sunitinib for first-line treatment of metastatic renal cell carcinoma.
Isabelle Chabot, Angela Rocchi

Value Health· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: the example of sunitinib for gastrointestinal stromal tumour.
Isabelle Chabot, Jacques LeLorier, Martin E Blackstein

Eur J Cancer· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in hypertension: the SF-12 compared to the SF-36.
Isabelle Côté, Jean-Pierre Grégoire, Jocelyne Moisan, Isabelle Chabot

Can J Clin Pharmacol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study.
Jean-Pierre Grégoire, Jocelyne Moisan, Louise Potvin, Isabelle Chabot, René Verreault

BMC Health Serv Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: what is the potential impact of the withdrawal of rofecoxib?
Elham Rahme, Elke Hunsche, Youssef Toubouti, Isabelle Chabot

Arthritis Rheum· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids.
Marc Dorais, Lucie Blais, Isabelle Chabot, Jacques LeLorier

J Asthma· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The societal value of universal childhood vaccination.
Isabelle Chabot, Mireille M Goetghebeur, Jean-Pierre Grégoire

Vaccine· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.
Ellen D Burgess, George W Carides, William C Gerth, Michael A Marentette, Isabelle Chabot

Can J Cardiol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist intervention program for control of hypertension.
Isabelle Chabot, Jocelyne Moisan, Jean-Pierre Grégoire, Alain Milot

Ann Pharmacother· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacy-based health promotion programme in hypertension: cost-benefit analysis.
Isabelle Côté, Jean-Pierre Grégoire, Jocelyne Moisan, Isabelle Chabot, Guy Lacroix

Pharmacoeconomics· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis